Cutler Group LP Arbutus Biopharma Corp Put Options Transaction History

Cutler Group LP

10 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2022 Oct 25, 2022	BUY	$1.88 - $2.88 $1,316 - $2,016	700 New	700 $0
Q1 2022 Apr 14, 2022	SELL	$2.42 - $3.98 $46,222 - $76,018	-19,100 Reduced 89.25%	2,300 $0
Q4 2021 Jan 18, 2022	BUY	$3.11 - $4.61 $65,932 - $97,732	21,200 Added 10600.0%	21,400 $19,000
Q3 2021 Oct 26, 2021	BUY	$2.65 - $4.62 $265 - $462	100 Added 100.0%	200 $0
Q2 2021 Jul 19, 2021	BUY	$2.5 - $3.51 $250 - $351	100 New	100 $0

Q2 2019 Aug 09, 2019	SELL	$1.46 - $4.44 $8,760 - $26,640	-6,000 Closed	0 $0
Q1 2019 May 10, 2019	SELL	$3.41 - $4.57 $6,820 - $9,140	-2,000 Reduced 25.0%	6,000 $10,000
Q3 2018 Nov 07, 2018	BUY	$7.85 - $12.35 $58,090 - $91,390	7,400 Added 1233.33%	8,000 $3,000
Q1 2018 May 11, 2018	BUY	$4.4 - $6.05 $2,200 - $3,025	500 Added 500.0%	600 $0
Q3 2017 Oct 17, 2017	BUY	$3.4 - $7.0 $340 - $700	100	100 $0

130

82.2M

4.82M

546K

Ticker ABUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,951,008
Market Cap $489M
Description
Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.